Cargando…
The development and prevalidation of an in vitro mutagenicity assay based on MutaMouse primary hepatocytes, Part I: Isolation, structural, genetic, and biochemical characterization
To develop an improved in vitro mammalian cell gene mutation assay, it is imperative to address the known deficiencies associated with existing assays. Primary hepatocytes isolated from the MutaMouse are ideal for an in vitro gene mutation assay due to their metabolic competence, their “normal” kary...
Autores principales: | Cox, Julie A., Zwart, Edwin P., Luijten, Mirjam, White, Paul A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590113/ https://www.ncbi.nlm.nih.gov/pubmed/30592088 http://dx.doi.org/10.1002/em.22253 |
Ejemplares similares
-
The development and prevalidation of an in vitro mutagenicity assay based on MutaMouse primary hepatocytes, Part II: Assay performance for the identification of mutagenic chemicals
por: Cox, Julie A., et al.
Publicado: (2019) -
In vivo mutagenicity assessment of styrene in MutaMouse liver and lung
por: Murata, Yasumasa, et al.
Publicado: (2023) -
In vivo mutagenicity assessment of orally treated tert-butyl hydroperoxide in the liver and glandular stomach of MutaMouse
por: Murata, Yasumasa, et al.
Publicado: (2023) -
The 28 + 28 day design is an effective sampling time for analyzing mutant frequencies in rapidly proliferating tissues of MutaMouse animals
por: Marchetti, Francesco, et al.
Publicado: (2021) -
Chemically induced mutations in a MutaMouse reporter gene inform mechanisms underlying human cancer mutational signatures
por: Beal, Marc A., et al.
Publicado: (2020)